Russia to begin Phase III trials of second COVID-19 vaccine in Nov-Dec -TASS

Russia will begin Phase III trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, in November-December, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Friday.

Early-stage clinical trials for the vaccine were completed on Wednesday. (Writing by Alexander Marrow; Editing by Polina Ivanova)

Also Read: Navalny ally says Russian investigation would show Putin responsible for poisoning